Marillion Pharmaceuticals India Profile
Key Indicators
- Authorised Capital ₹ 0.99 M
as on 02-05-2024
- Paid Up Capital ₹ 0.97 M
as on 02-05-2024
- Company Age 19 Year, 21 Days
- Last Filing with ROC 31 Mar 2017
- Revenue %
(FY 2016)
- Profit -502475.35%
(FY 2016)
- Ebitda -502475.35%
(FY 2016)
- Net Worth -100.02%
(FY 2016)
- Total Assets -99.90%
(FY 2016)
About Marillion Pharmaceuticals India
- CIN/LLPIN
U24239TG2005PTC048633
- Company No.
048633
- Company Classification
Private Limited Indian Non-Government Company
- Incorporation Date
29 Dec 2005
- Date of AGM
29 Sep 2017
- Date of Balance Sheet
31 Mar 2017
- Listing Status
Unlisted
- ROC Code
Roc Hyderabad
Industry
Company Details
- Location
K.V.Rangareddy, Telangana, India
- Telephone
- Email Address
- Website
-
- Social Media-
Who are the key members and board of directors at Marillion Pharmaceuticals India?
Board Members(3)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Samiullah Syed  | Director | 30-Sep-2014 | Current |
| Vishnu Kamalapuri | Director | 28-Jun-2015 | Current |
Zahed Subhan  | Director | 29-Dec-2005 | Current |
Financial Performance of Marillion Pharmaceuticals India.
Marillion Pharmaceuticals India Private Limited, for the financial year ended 2016, experienced no change in revenue, with a 0% increase. The company also saw a substantial fall in profitability, with a 502475.35% decrease in profit. The company's net worth observed a substantial decline by a decrease of 100.02%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metric |
| (FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue | |||||||
| Revenue from Operations | |||||||
| Total Assets |
| ||||||
| Profit or Loss |
| ||||||
| Net Worth |
| ||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Marillion Pharmaceuticals India?
In 2017, Marillion Pharmaceuticals India had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Related Corporates (Common Directorship)
Ventureast Social Investment Trustee Private LimitedActive 17 years 1 monthVishnu Kamalapuri and Samiullah Syed are mutual person
- Ventureast Micro-Equity Managers Private LimitedActive 17 years 2 months
Vishnu Kamalapuri and Samiullah Syed are mutual person
- Ventureast Drug Discovery Services Private LimitedActive 18 years 5 months
Vishnu Kamalapuri is a mutual person
- Ventureast Investment Advisors Private LimitedActive 8 years 8 months
Vishnu Kamalapuri is a mutual person
E To E Operations And Maintenance Private LimitedActive 15 years 11 monthsVishnu Kamalapuri is a mutual person
Charges (Loans)
There are no open charges registered against the company as per our records.
How Many Employees Work at Marillion Pharmaceuticals India?
Unlock and access historical data on people associated with Marillion Pharmaceuticals India, such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Marillion Pharmaceuticals India, offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Marillion Pharmaceuticals India's trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.
